Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China
GHDx Entry last modified on: Jan 31, 2024
COVID-19
Dataset Records for COVID-19
Displaying 851 - 900 of 1560
Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020
GHDx Entry last modified on: Jan 31, 2024
Searching for COVID-19 Antibodies in Czech Children-A Needle in the Haystack
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study
GHDx Entry last modified on: Mar 14, 2022
A Single-centre Study of COVID-19 Antibody
GHDx Entry last modified on: Mar 14, 2022
Low seroprevalence of COVID-19 in Lao PDR, late 2020
GHDx Entry last modified on: Mar 14, 2022
Longitudinal SARS-CoV-2 seroprevalence in a rural and urban community household cohort in South Africa, during the first and second waves July 2020-March 2021. Preprint
GHDx Entry last modified on: May 12, 2022
Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients
GHDx Entry last modified on: Mar 14, 2022
Armenia COVID-19 Rapid Gender Assessment Survey 2020
Survey:
Cross-sectional - Individual - Interview
Population-Based Study of anti-SARS-CoV-2, Social Distancing and Government Responses in Joinville, Brazil. Preprint
GHDx Entry last modified on: Mar 14, 2022
Risk factors and predictors that influence SARS-Cov-2 IgG positivity: A cross-sectional study of blood donors in Riyadh, Saudi Arabia
GHDx Entry last modified on: Mar 14, 2022
I SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021
GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 infection among children in Children's Hospital Zagreb during the initial and second wave of COVID-19 pandemic in Croatia
GHDx Entry last modified on: Mar 14, 2022
A cross-sectional study of immune seroconversion to SARS-CoV-2 in frontline maternity health professionals
GHDx Entry last modified on: Mar 14, 2022
Slow Spread of SARS-CoV-2 in Southern Brazil Over a 6-Month Period: Report on 8 Sequential Statewide Serological Surveys Including 35611 Participants
GHDx Entry last modified on: Jan 31, 2024
Long COVID 1 year after hospitalisation for COVID-19: a prospective bicentric cohort study
GHDx Entry last modified on: Apr 10, 2023
Maternal and perinatal characteristics and outcomes of pregnancies complicated with COVID-19 in Kuwait
GHDx Entry last modified on: Apr 10, 2023
Pregnancy and risk of COVID-19: a Norwegian registry-linkage study
GHDx Entry last modified on: Apr 10, 2023
The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS)
GHDx Entry last modified on: Apr 10, 2023
Sociodemographic Predictors of SARS-CoV-2 Infection in Obstetric Patients, Georgia, USA
GHDx Entry last modified on: Apr 10, 2023
Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 Months
GHDx Entry last modified on: Mar 22, 2024
Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study
GHDx Entry last modified on: Mar 22, 2024
Initial symptoms and three months follow-up after acute COVID-19 in outpatients: An international prospective cohort study
GHDx Entry last modified on: Mar 22, 2024
COVID-19 in Older Patients: Assessment of Post-COVID-19 Sarcopenia
GHDx Entry last modified on: Mar 22, 2024
Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study
GHDx Entry last modified on: Oct 23, 2024
Mexico Health Secretary COVID-19 Daily Technical Report 2020
Comunicado Técnico Diario COVID-19 MÉXICO
Humoral Immune Response to SARS-CoV-2 in Iceland
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium - a serial prospective cross-sectional nationwide study of residual samples. Preprint
Scientific literature:
Cross-sectional
Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study. Preprint
GHDx Entry last modified on: Mar 14, 2022
New onset neurologic events in people with COVID-19 in 3 regions in China
GHDx Entry last modified on: Jan 31, 2024
Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study
GHDx Entry last modified on: Mar 14, 2022
Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Infection on Pregnant Women and Their Infants
GHDx Entry last modified on: Jan 31, 2024
Neonatal outcome in 29 pregnant women with COVID-19: A retrospective study in Wuhan, China
GHDx Entry last modified on: Jan 31, 2024
Long-term COVID-19 symptoms in a large unselected population. Preprint
GHDx Entry last modified on: Apr 10, 2023
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
GHDx Entry last modified on: Jan 31, 2024
Risk of COVID-19 in health-care workers in Denmark: an observational cohort study
GHDx Entry last modified on: Mar 14, 2022
New Zealand Monthly Notifiable Disease Surveillance Report, January 2021
Epi surveillance:
Subnationally representative
A longitudinal seroprevalence study in a large cohort of working adults reveals that neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independent of the severity of symptoms. Preprint
GHDx Entry last modified on: Jun 18, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Fatality Rate Among Elderly Danes: A Cross-sectional Study on Retired Blood Donors
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 Antibodies in Adults and Healthcare Workers in Southern Italy
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 seroprevalence and detection fraction in Utah urban populations from a probability-based sample. Preprint.
GHDx Entry last modified on: Mar 14, 2022
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
GHDx Entry last modified on: Jan 31, 2024
Prevalence of COVID-19 in Iran: results of the first survey of the Iranian COVID-19 Serological Surveillance programme
GHDx Entry last modified on: May 12, 2022
Serological identification of past and recent SARS-CoV-2 infection through antibody screening in Luanda, Angola
GHDx Entry last modified on: Mar 14, 2022
[Collective immunity to SARS-CoV-2 of Moscow residents during the COVID-19 epidemic period]
Коллективный иммунитет к SARS-CoV-2 жителей Москвы в эпидемический период COVID-19
Population seroprevalence of SARS-CoV-2 antibodies in Anambra State, South-East, Nigeria
GHDx Entry last modified on: May 12, 2022
Lung Function sequelae in COVID-19 Patients 3 Months After Hospital Discharge
GHDx Entry last modified on: Apr 10, 2023
Subscribe